ABCG2 p.Thr402Leu

[switch to full view]
Comments [show]
Publications
PMID: 20088606 [PubMed] Polgar O et al: "Mutational analysis of threonine 402 adjacent to the GXXXG dimerization motif in transmembrane segment 1 of ABCG2."
No. Sentence Comment
4 Single mutations to leucine (T402L) or arginine (T402R) did not have a significant impact on the ABCG2 protein.
X
ABCG2 p.Thr402Leu 20088606:4:29
status: VERIFIED
Login to comment

5 On the other hand, combining the T402 mutations with the GXXXG glycine to leucine mutations (T402L/ G406L/G410L and T402R/G406L/G410L) resulted in a substantially reduced level of expression, altered glycosylation, degradation by a proteosome-independent pathway, and partial retention in the endoplasmic reticulum as suggested by immunostaining, Endo H sensitivity, and MG132 and bafilomycin failed effect.
X
ABCG2 p.Thr402Leu 20088606:5:93
status: VERIFIED
Login to comment

6 The T402L/G406L/G410L mutant when incubated with the ABCG2 substrate MX showed a shift on immunoblot analysis to the band representing the fully mature glycoprotein.
X
ABCG2 p.Thr402Leu 20088606:6:4
status: VERIFIED
Login to comment

45 The T402L, T402R, T402L/ G406L/G410L, and T402R/G406L/G410L mutants were generated by site-directed mutagenesis in the pcDNA3.1/Myc-HisA(-) vector (Invitrogen) as previously described (19).
X
ABCG2 p.Thr402Leu 20088606:45:4
status: VERIFIED
X
ABCG2 p.Thr402Leu 20088606:45:18
status: VERIFIED
Login to comment

92 To study the potential role of this threonine in ABCG2 dimerization, we performed substitutions with a leucine (T402L) or arginine (T402R) substitution or combined these substitutions with the glycine to leucine mutations at the GXXXG motif (T402L/ G406L/G410L and T402R/G406L/G410L) followed by stable transfections in HEK 293 cells.
X
ABCG2 p.Thr402Leu 20088606:92:112
status: VERIFIED
X
ABCG2 p.Thr402Leu 20088606:92:242
status: VERIFIED
Login to comment

93 The T402L mutation was designed to probe the perceived involvement of this residue in hydrogen bonding.
X
ABCG2 p.Thr402Leu 20088606:93:4
status: VERIFIED
Login to comment

101 The T402L and T402R mutants exhibited levels comparable to the control (R482G), while the double (G406L/G410L) and triple mutants (T402L/G406L/G410L and T402R/G406L/G410L) had significantly decreased levels.
X
ABCG2 p.Thr402Leu 20088606:101:4
status: VERIFIED
X
ABCG2 p.Thr402Leu 20088606:101:131
status: VERIFIED
Login to comment

106 As shown in the first column of Figure 1B, the control (R482G) and the T402L and T402R mutants displayed similar levels of surface expression.
X
ABCG2 p.Thr402Leu 20088606:106:71
status: VERIFIED
Login to comment

107 The G406L/G410L and T402L/G406L/G410L mutants displayed substantially lower surface expression levels with the 5D3 antibody.
X
ABCG2 p.Thr402Leu 20088606:107:20
status: VERIFIED
Login to comment

114 The control and the T402L and T402Rmutants wereable toefflux MX,pheophorbide a, and BODIDY-prazosin from the cells.
X
ABCG2 p.Thr402Leu 20088606:114:20
status: VERIFIED
Login to comment

122 As expected, no change in molecular mass was observed in the control, T402L, or T402R after Endo H digestion (Figure 2A), since Endo H resistance is consistent with a fully mature glycoprotein.
X
ABCG2 p.Thr402Leu 20088606:122:70
status: VERIFIED
Login to comment

130 (A) Cell lysates from stably transfected HEK 293 cells (20 μg for R482G, T402L, and T402R and 60 μg for G406L/G410L, T402L/G406L/G410L, and T402R/G406L/G410L) were separated via SDS-PAGE, transferred onto a PVDF membrane, and probed with monoclonal anti-ABCG2 antibody BXP-21.
X
ABCG2 p.Thr402Leu 20088606:130:79
status: VERIFIED
X
ABCG2 p.Thr402Leu 20088606:130:129
status: VERIFIED
Login to comment

135 On the other hand, the protein level of the control, T402R, and T402L proteins increased more than 2-fold when cells were treated with bafilomycin, consistent with a previous report that fully processed ABCG2 undergoes lysosomal degradation as part of the protein turnover (33).
X
ABCG2 p.Thr402Leu 20088606:135:64
status: VERIFIED
Login to comment

136 In contrast, the protein levels of the G406L/G410L, T402L/G406L/G410L, and T402R/G406L/ G410L mutants were little affected by bafilomycin treatment (Figure 3).
X
ABCG2 p.Thr402Leu 20088606:136:52
status: VERIFIED
Login to comment

142 In the case of the control, T402L, and T402R proteins, no significant differences between the MX-treated and untreated samples were observed (Figure 4A).
X
ABCG2 p.Thr402Leu 20088606:142:28
status: VERIFIED
Login to comment

144 In contrast, overnight treatment with MX resulted in a majority of the T402L/G406L/G410L mutant being detected in the normal 72 kDa band as opposed to the double band observed without drug exposure, representing a shift from the lower to the upper molecular mass band (Figure 4A).
X
ABCG2 p.Thr402Leu 20088606:144:71
status: VERIFIED
Login to comment

147 No change was observed in the mainly plasma membrane staining for the control, T402L, and T402R proteins after treatment with MX by confocal microscopy (Figure 5).
X
ABCG2 p.Thr402Leu 20088606:147:79
status: VERIFIED
Login to comment

148 The G406L/G410L mutant exhibited primarily plasma membrane staining with little intracellular signal and after MX treatment displayed a slightly increased level of surfaceexpression.InthecaseoftheT402L/G406L/G410Lmutant, both intracellular and cell surface staining could be observed prior to treatment with MX, while after overnight MX treatment, we observed an increased level of ABCG2 plasma membrane localization in the T402L/G406L/G410L mutant (Figure 5).
X
ABCG2 p.Thr402Leu 20088606:148:424
status: VERIFIED
Login to comment

151 As demonstrated in Figure 6, following MX treatment, the T402L/G406L/G410L mutant was no longer sensitive to Endo H (Figure 6B), implying that its glycan has matured and that the protein has most likely moved out of the ER.
X
ABCG2 p.Thr402Leu 20088606:151:57
status: VERIFIED
Login to comment

155 Immunoblot analysis of cell lysates from the R482G, T402L, and T402R mutants [(A) 35 μg] and from the G406L/G410L, T402L/G406L/G410L, and T402R/G406L/G410L mutants [(B) 70 μg] with the BXP-21 antibody following overnight treatment with Endo H or N-glycosidase F.
X
ABCG2 p.Thr402Leu 20088606:155:52
status: VERIFIED
X
ABCG2 p.Thr402Leu 20088606:155:121
status: VERIFIED
Login to comment

158 Cells were harvested after overnight incubation with or without 10 nM bafilomycin followed by immunoblot analysis with the BXP-21 and GAPDH antibodies for the R482G, T402L, and T402R mutants (40 μg/lane) and the G406L/G410L, T402L/G406L/G410L, and T402R/G406L/G410L mutants (100 μg/lane).
X
ABCG2 p.Thr402Leu 20088606:158:166
status: VERIFIED
X
ABCG2 p.Thr402Leu 20088606:158:231
status: VERIFIED
Login to comment

166 (A) Following overnight incubation with or without 5 μM MX, cells were harvested, and the lysates (25 μg for R482G, T402R, and T402L and 50 μg for the other mutants) were subjected to immunoblot analysis with the BXP-21 and GAPDH antibodies as described in the legend of Figure 1.
X
ABCG2 p.Thr402Leu 20088606:166:139
status: VERIFIED
Login to comment

171 Similar results were obtained with the T402L and T402L/G406L/G410L mutants with DSG; furthermore, the triple mutants were also cross-linked by DSS at both 4 °C and room temperature (data not shown).
X
ABCG2 p.Thr402Leu 20088606:171:39
status: VERIFIED
X
ABCG2 p.Thr402Leu 20088606:171:49
status: VERIFIED
Login to comment

190 When created insilico, the T402L mutation does not appear to interfere with interhelix packing between TM1 and TM5 and TM6 of its adjacent subunit (Figure 9D), which is consistent with the biochemical data for this mutant.
X
ABCG2 p.Thr402Leu 20088606:190:27
status: VERIFIED
Login to comment

196 After overnight incubation with or without 5 μM MX, cells were harvested, and the lysates were subjected to overnight digestion with Endo H followed by immunoblot analysis with the BXP-21 antibody [(A) 35 μg for R482G, T402R, and T402L and (B) 70 μg for the double and triple mutants].
X
ABCG2 p.Thr402Leu 20088606:196:242
status: VERIFIED
Login to comment

199 Cross-linking is observed in the control, T402L, T402R, and the triple mutants as suggested by higher-molecular mass species.
X
ABCG2 p.Thr402Leu 20088606:199:42
status: VERIFIED
Login to comment

204 Following incubation with the ABCG2 substrate, MX, T402L/T406L/T410L readily shifted to the plasma membrane while T402R/T406L/T410L did not.
X
ABCG2 p.Thr402Leu 20088606:204:51
status: VERIFIED
Login to comment

217 Under the consideration that the GXXXG motif in TM1 may be involved in the dimer interface, or alternatively, in a transient interaction with the TM1 of a neighboring subunit, we chose to substitute threonine with leucine at position 402 in the mammalian system to replace a polar with a nonpolar residue, similar to the substitution disruptive of Thr87 with Val in glycophorin A (22), and in doing so also introduced a small increase in size.
X
ABCG2 p.Thr402Leu 20088606:217:199
status: VERIFIED
Login to comment

219 More importantly, we wanted to use the T402L substitution to probe the existence of the perceived hydrogen bonding interaction by T402.
X
ABCG2 p.Thr402Leu 20088606:219:39
status: VERIFIED
Login to comment

220 The wild-type phenotype of the T402L mutant argues against H-bonding at this residue.
X
ABCG2 p.Thr402Leu 20088606:220:31
status: VERIFIED
Login to comment

228 This point is supported by the efficient shift of the lower band in the MX rescue experiments for the T402L and T402L/G406L/ G410L mutants discussed below.
X
ABCG2 p.Thr402Leu 20088606:228:102
status: VERIFIED
X
ABCG2 p.Thr402Leu 20088606:228:112
status: VERIFIED
Login to comment

233 Our results with the ABCG2 triple mutants carrying the threonine 402 to leucine or arginine substitutions (T402R/ G406L/G410L and T402R/G406L/G410L) are consistent with destabilization of the homodimer.
X
ABCG2 p.Thr402Leu 20088606:233:55
status: VERIFIED
Login to comment

244 (D) Close-up view of the T402L mutation.
X
ABCG2 p.Thr402Leu 20088606:244:25
status: VERIFIED
Login to comment

246 (F) Close-up view of the T402L, G406L, and G410L mutations.
X
ABCG2 p.Thr402Leu 20088606:246:25
status: VERIFIED
Login to comment

256 As noted above, the T402L/G406L/G410L mutant could be rescued by overnight treatment with the substrate MX as suggested by its shift to the normal 72 kDa molecular mass band on immunoblot and its loss of Endo H sensitivity.
X
ABCG2 p.Thr402Leu 20088606:256:20
status: VERIFIED
Login to comment

PMID: 20739628 [PubMed] Ni Z et al: "Transmembrane helices 1 and 6 of the human breast cancer resistance protein (BCRP/ABCG2): identification of polar residues important for drug transport."
No. Sentence Comment
287 Two mutants of Thr402 , T402L and T402R, were generated in that study.
X
ABCG2 p.Thr402Leu 20739628:287:24
status: VERIFIED
Login to comment

PMID: 21991363 [PubMed] Haider AJ et al: "Dimerization of ABCG2 analysed by bimolecular fluorescence complementation."
No. Sentence Comment
164 However, it remains possible that the effects of multiple mutations to a predicted interfacial site could be detected by BiFC, e.g. the surface of helix TM1 which contains a T402L/G406L/G410L dimerization motif [17].
X
ABCG2 p.Thr402Leu 21991363:164:174
status: NEW
Login to comment

PMID: 23307580 [PubMed] George RL et al: "Genetics of hyperuricemia and gout: implications for the present and future."
No. Sentence Comment
198 In the context of gout, the ABCG2 ligand mitoxantrone (an ABCG2 ligand) improved the altered protein structure of the T402L-G404L-G406L-G410L mutant in vitro [66].
X
ABCG2 p.Thr402Leu 23307580:198:118
status: NEW
Login to comment

PMID: 24021215 [PubMed] Stacy AE et al: "Molecular pharmacology of ABCG2 and its role in chemoresistance."
No. Sentence Comment
73 Mutational analysis of Thr402, which is located near the GXXXG motif (TXXGXXXG), in combination with mutations of the GXXXG motif (T402L or T402R and G406L or G410L; Fig. 3) resulted in a reduction in protein expression and drug efflux, alterations in glycosylation, and retention of ABCG2 in the ER (Polgar et al., 2010).
X
ABCG2 p.Thr402Leu 24021215:73:131
status: NEW
Login to comment